BAKER BROS. ADVISORS LP CRSP Holdings History
BAKER BROS. ADVISORS LP's CRISPR Therapeutics AG Holding Summary
As of 2025-03-31, BAKER BROS. ADVISORS LP held 654,099.00 shares of CRISPR Therapeutics AG(CRSP), totaling $22.26 Mil. This investment constitutes 0.25% of their stock portfolio, and BAKER BROS. ADVISORS LP now holds 0.76% of the outstanding CRISPR Therapeutics AG(CRSP) stock.
The initial trade took place in 2024Q2. And since then BAKER BROS. ADVISORS LP has made 3 purchases of CRSP, at an average price of $50.04, for a total of 1.31 Mil shares. In addition, there have been 1 sales at an average price of $42.39 for 653,912.00 shares. Based on historical transaction data and CRSP's current price of $55.69, BAKER BROS. ADVISORS LP's estimated gain on his CRSP holdings is $-1.31 Mil, reflecting a -2.01% gain to date.
BAKER BROS. ADVISORS LP CRSP ($55.69) Holding Chart
BAKER BROS. ADVISORS LP CRSP ($55.69) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
